Insulet Beheer
Beheer criteriumcontroles 3/4
De CEO Insulet is Jim Hollingshead, benoemd in Jun2022, heeft een ambtstermijn van 2.42 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 12.38M, bestaande uit 6.8% salaris en 93.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.025% van de aandelen van het bedrijf, ter waarde $ 4.66M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.9 jaar en 4 jaar.
Belangrijke informatie
Jim Hollingshead
Algemeen directeur
US$12.4m
Totale compensatie
| Percentage CEO-salaris | 6.8% |
| Dienstverband CEO | 2.4yrs |
| Eigendom CEO | 0.02% |
| Management gemiddelde ambtstermijn | 1.9yrs |
| Gemiddelde ambtstermijn bestuur | 4yrs |
Recente managementupdates
Recent updates
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20Does This Valuation Of Insulet Corporation (NASDAQ:PODD) Imply Investors Are Overpaying?
Nov 20
Returns At Insulet (NASDAQ:PODD) Are On The Way Up
Nov 08Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues
Oct 15Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Oct 03Is Insulet (NASDAQ:PODD) A Risky Investment?
Sep 09Insulet: Turning More Constructive, Valuations Still Stretched
Sep 05Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching
Aug 28Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings
Aug 16A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Jul 15Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$421m |
| Jun 30 2024 | n/a | n/a | US$395m |
| Mar 31 2024 | n/a | n/a | US$234m |
| Dec 31 2023 | US$12m | US$842k | US$206m |
| Sep 30 2023 | n/a | n/a | US$120m |
| Jun 30 2023 | n/a | n/a | US$63m |
| Mar 31 2023 | n/a | n/a | US$600k |
| Dec 31 2022 | US$11m | US$440k | US$5m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$45m |
| Dec 31 2021 | US$290k | n/a | US$17m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$259k | n/a | US$7m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$18m |
| Mar 31 2020 | n/a | n/a | US$5m |
| Dec 31 2019 | US$261k | n/a | US$12m |
Compensatie versus markt: De totale vergoeding ($USD 12.38M ) Jim } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.64M ).
Compensatie versus inkomsten: De vergoeding van Jim is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Jim Hollingshead (61 yo)
2.4yrs
Tenure
US$12,379,765
Compensatie
Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 2.4yrs | US$12.38m | 0.025% $ 4.7m | |
| Group VP | 5.6yrs | US$1.44m | 0.0061% $ 1.1m | |
| Senior VP & CTO | 1.3yrs | US$2.37m | 0.014% $ 2.6m | |
| Senior VP & General Counsel | 5.7yrs | US$2.47m | 0.021% $ 4.0m | |
| Executive VP | 6.8yrs | US$3.14m | 0.024% $ 4.5m | |
| Executive VP | less than a year | geen gegevens | 0.00014% $ 26.2k | |
| Senior Vice President of Global Operations | 1.8yrs | geen gegevens | 0.0052% $ 974.2k | |
| Senior Director of Investor Relations | no data | geen gegevens | geen gegevens | |
| Senior VP of Regulatory Affairs | 1.9yrs | geen gegevens | 0.0044% $ 828.4k | |
| Senior Director of Corporate Communications | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Sales & Customer Care | 9.8yrs | geen gegevens | geen gegevens | |
| Senior VP of Strategy & Corporate Development | less than a year | geen gegevens | geen gegevens |
1.9yrs
Gemiddelde duur
50.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van PODD wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.9 jaar), wat duidt op een nieuw team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 5.3yrs | US$12.38m | 0.025% $ 4.7m | |
| Independent Director | 2.8yrs | US$322.50k | 0.0040% $ 740.5k | |
| Independent Chairman | 10.3yrs | US$387.10k | 0.042% $ 7.8m | |
| Chairman of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Educator Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Educator Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Educator Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Educator Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | less than a year | geen gegevens | geen gegevens |
4.0yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van PODD wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).